Altogether, these results demonstrate that NKX2.5 is the primarily regulator of CM-specific LIPTER transcription and that hyperglycaemia can repress the NKX2.5–LIPTER axis expression in human CMs. The gene discussed is NKX2-5; the disease is Hyperglycemia.